跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 51,116 条关于
“infusion-related reactions”
全部
51,116
临床试验
37,851
药物
700
机构
112
资讯
12,453
2年前
Dexamethasone Significantly Reduces Infusion-Related Reactions with Amivantamab in EGFR-Mutated NSCLC
2年前
Dexamethasone Prophylaxis Reduces Infusion-Related Reactions with Amivantamab in EGFR-Mutated NSCLC
去年
Enhanced Premedication Protocol Reduces Infusion Reactions in NSCLC Patients Receiving Amivantamab
2年前
Johnson & Johnson's Rybrevant and Lazcluze Combination Shows Reduced Infusion Reactions in NSCLC Trial
8个月前
Panitumumab Emerges as Viable Alternative to Cetuximab in BRAF-Mutated Colorectal Cancer Treatment
2年前
BRIUMVI Rapid Infusion Shows Promise in Multiple Sclerosis Treatment
去年
FDA Approvals Expand Amivantamab's Role in EGFR-Mutated NSCLC Treatment
去年
FDA Approves Zanidatamab for HER2-Positive Biliary Tract Cancer
2年前
FDA Approves Lilly's Kisunla (donanemab-azbt) for Early Symptomatic Alzheimer's Disease
去年
Managing Amivantamab's Complex Safety Profile: New Strategies for EGFR-Positive NSCLC Treatment
第 1 页，共 1246 页
上一页
下一页
